J&J Oklahoma Judgement May Set Benchmark For Massive Opioid Resolution
Executive Summary
Judge orders J&J to pay $572m for one-year abatement plan; the state had proposed $12bn over 20-year period. J&J's gamble on a trial has so far not succeeded, since it is now facing more than twice the payout that Purdue agreed to in a settlement.
You may also be interested in...
Selling Opioids Is Not A Public Nuisance For Three Reasons, Oklahoma State Appeals Court Rules
Overturning a $465m verdict against J&J, Oklahoma Supreme Court rejects claim opioid sales violated a public right. It says a manufacturer does not have control of its product once it is sold and cannot be held perpetually liable for its products.
Can California Opioid Ruling Help Manufacturers In Pending Cases?
Judge’s dismissal of all claims against opioid makers offers hope they can win other cases and may push forward settlements. But it is ‘bookend’ by the Oklahoma case that reached a dramatically divergent conclusion, so while significant, it is only a single data point, Stanford law professor says.
Legislators Seek US FDA Input On Teva Proposed Opioid Settlement
Reps. McKinley and Kaptur ask commissioner Hahn about potential for shortages if Teva’s proposal to provide free opioid addiction treatment goes into effect. States are pushing for more money and stricter injunctive terms in settlement talks with manufacturers and distributers.